This article contains promotional content. (September 2023) |
Company type | Public |
---|---|
Industry | Pharmaceuticals |
Founded | April 7, 2014 |
Founder | Vivek Ramaswamy |
Headquarters | London, United Kingdom |
Key people | Matt Gline (CEO) |
Revenue | US$125 million (2024) |
US$4.24 billion (2024)[a] | |
US$4.35 billion (2024)[a] | |
Total assets | US$7.22 billion (2024)[a] |
Total equity | US$6.45 billion (2024)[a] |
Owner | Vivek Ramaswamy (10.5%) |
Number of employees | 908 (2024) |
Website | roivant |
Footnotes / references Financials as of 31 March 2024[update].[1][2] |
Roivant Sciences Ltd. is a healthcare company focused on applying technology to drug development and building subsidiary biotech and healthcare technology companies. It was founded in 2014 by Vivek Ramaswamy.[3]
Cite error: There are <ref group=lower-alpha>
tags or {{efn}}
templates on this page, but the references will not show without a {{reflist|group=lower-alpha}}
template or {{notelist}}
template (see the help page).